# The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis

> **NCT02977117** · PHASE2 · COMPLETED · sponsor: **Iain Bressendorff** · enrollment: 59 (actual)

## Conditions studied

- Endstage Renal Disease

## Interventions

- **OTHER:** Dialysate magnesium (1.0 mmol/L)
- **OTHER:** Dialysate magnesium (0.5 mmol/L)

## Key facts

- **NCT ID:** NCT02977117
- **Lead sponsor:** Iain Bressendorff
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02977117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02977117, "The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02977117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*